Sign In
Buy OGN
$13.56
+0 (+0%)
At Close: Aug 04, 2026
Accenture and Organon Team Up to Drive Digital Transformation for Better Patient and Employee Experiences
06:59pm, Wednesday, 17'th Nov 2021 Business Wire
NEW YORK--(BUSINESS WIRE)--Accenture was selected by Organon to transform the companys enterprise resource planning technology into a cloud-based digital core.
Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows
10:55am, Wednesday, 17'th Nov 2021 The Motley Fool
Past spinoffs by other companies could bode well overall for J&J shareholders.
Te Ahumairangi Investment Management Ltd Buys VeriSign Inc, Skechers USA Inc, Organon, Sells ...
03:38pm, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: VRSN , SKX , WPC , OGN , TTWO , LYB , CRSR , WELL , LNC , NFLX , AMT , INN ,
Buffett Continues to Sell Stock as Turnover Increases
11:14am, Tuesday, 16'th Nov 2021
Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway ( BRK.A , Financial) ( BRK.B , Financial) published its third-quarter 13F filing earlier this week, reporting U.S. equity position changes durin
Truist Securiti Weighs in on Organon & Co.s Q4 2021 Earnings (NYSE:OGN)
07:48am, Tuesday, 16'th Nov 2021 Transcript Daily
Organon & Co. (NYSE:OGN) Stock analysts at Truist Securiti reduced their Q4 2021 earnings estimates for Organon & Co. in a research report issued on Thursday, November 11th. Truist Securiti analyst G. Fraser now forecasts that the company will post earnings per share of $1.29 for the quarter, down from their previous forecast of []
Warren Buffet''s Berkshire Hathaway cuts Merck stakes, invests in drug royalty company
03:41am, Tuesday, 16'th Nov 2021 Business Today
Berkshire also eliminated its small stakes in Organon & Co, a Merck spinoff specializing in contraception and other women''s health products, and telecommunications company Liberty Global Plc.
Is SPDRSP PHARMA (XPH) a Strong ETF Right Now?
03:21pm, Monday, 15'th Nov 2021 Zacks Investment Research
Smart Beta ETF report for XPH
Analysts Set Organon & Co. (NYSE:OGN) Price Target at $39.63
02:56pm, Monday, 15'th Nov 2021 Dakota Financial News
Shares of Organon & Co. (NYSE:OGN) have been assigned a consensus rating of Hold from the ten analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating on the company. The average 12-month []
Organon & Co. (OGN) To Go Ex-Dividend on November 19th
12:14pm, Sunday, 14'th Nov 2021 Transcript Daily
Organon & Co. (NYSE:OGN) declared a quarterly dividend on Friday, November 12th, Wall Street Journal reports. Investors of record on Monday, November 22nd will be given a dividend of 0.28 per share on Thursday, December 16th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 3.32%. The ex-dividend date of []
Organon: Post Earnings Dip Is A Buy Opportunity Based On Jaw-Dropping Fundamentals
07:38pm, Friday, 12'th Nov 2021
Organon was formed via the spin-out of Merck's Women's Health, Biosimilars and Established Brands divisions - shares began trading in May. On Nov. 11, the company reported Q321 earnings, affirming FY2
Organon & Co. (OGN) CEO Kevin Ali on Q3 2021 Earnings Conference Call - Earnings Call Transcript
01:43pm, Thursday, 11'th Nov 2021
Organon & Co. (OGN) CEO Kevin Ali on Q3 2021 Earnings Conference Call - Earnings Call Transcript
Organon's (OGN) Earnings & Revenues Surpass Estimates in Q3
12:59pm, Thursday, 11'th Nov 2021
Organon's (OGN) earnings and revenues trump estimates in the third quarter of 2021. Shares down in pre-market trading.
Organon's stock slides after announcing deal with Forendo Pharma
11:42am, Thursday, 11'th Nov 2021
Shares of Organon & Co. OGN, -6.36% were down 6.7% in trading on Thursday after the company said it plans to acquire Forendo Pharma, a privately held company developing an endometriosis therapy. As pa
Organon (OGN) to Report Q3 Earnings: What's in the Cards?
01:03pm, Monday, 08'th Nov 2021
Organon (OGN) is set to provide updates on its earnings and revenues when it reports third-quarter 2021 results.
Here's Why Warren Buffett Isn't Buying Many Stocks Right Now
05:52am, Sunday, 17'th Oct 2021
And why you might want to copy the legendary investor's cautious approach.
